- 2024-08-20 02:14抑制剂TFAP|TFAP|1011244-68-0|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:14抑制剂TFAP|TFAP|1011244-68-0|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:14抑制剂Tecadenoson|Tecadenoson|204512-90-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:14抑制剂Tecalcet Hydrochloride|Tecalcet Hydrochloride|177172-49-5|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:14抑制剂Tecalcet Hydrochloride|Tecalcet Hydrochloride|177172-49-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:14抑制剂Tecalcet Hydrochloride|Tecalcet Hydrochloride|177172-49-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:14抑制剂TDZD-8|TDZD-8|327036-89-5|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:14抑制剂TDZD-8|TDZD-8|327036-89-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:14抑制剂TDZD-8|TDZD-8|327036-89-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:14抑制剂Tecadenoson|Tecadenoson|204512-90-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:14抑制剂TCS PrP Inhibitor 13|TCS PrP Inhibitor 13|34320-83-7|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:14抑制剂TCS PrP Inhibitor 13|TCS PrP Inhibitor 13|34320-83-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:14抑制剂TCS PrP Inhibitor 13|TCS PrP Inhibitor 13|34320-83-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:14抑制剂TCO-NHS ester|TCO-NHS ester|1191901-33-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:14抑制剂TC-S 7005|TC-S 7005|1082739-92-1|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:14抑制剂TC-S 7005|TC-S 7005|1082739-92-1|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:14抑制剂TC-S 7005|TC-S 7005|1082739-92-1|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:14抑制剂TCN 213|TCN 213|556803-08-8|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:14抑制剂TCN 213|TCN 213|556803-08-8|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:14抑制剂TCN 213|TCN 213|556803-08-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
